Oversubscribed Shortfall Offer & Placement raise 1.75m
Filed with ASX · · 2 pages · English
Summary by 6ix AI
Curvebeam AI Ltd. has announced the results of its oversubscribed Shortfall Offer and Placement, raising funds to support its expansion in China. CEO Greg Brown highlighted the recent FDA clearance of their CT-based Bone Mineral Density technology as a key milestone for future growth. The funds will be allocated towards sales, marketing, research and development, and supply chain costs related to the China market launch.
Written by 6ix AI from the company’s filing. How 6ix writes summaries
Earlier from Curvebeam AI
- Update - Proposed issue of securities - CVB
- FDA 510(k) Clearance CT-based BMD Technology
- Application for quotation of securities - CVB
- Change in substantial holding
- Becoming a substantial holder - Intellivision Holdings
Later from Curvebeam AI
- Proposed issue of securities - CVB
- Ceasing to be a substantial holder
- Cleansing Notice for Shortfall Overflow Placement
- Date of 2026 Annual General Meeting
Follow Curvebeam AI into a list and get an email when it puts out news.
Follow Curvebeam AI